3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
7
UNKNOWN
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
33
Esophageal Neoplasms
14
Stomach Neoplasms
11
Rectal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Triple Negative Breast Neoplasms
8
Colorectal Neoplasms
8
Small Cell Lung Carcinoma
7
Squamous Cell Carcinoma of Head and Neck
6
Neoplasm Metastasis
6
Lung Neoplasms
6
Brain Neoplasms
6
Neoplasms
5
Esophageal Squamous Cell Carcinoma
5
Recurrence
3
Nasopharyngeal Carcinoma
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Hormone Receptor Positive Advanced Breast Cancer
3
Head and Neck Neoplasms
3
HER2-positive Breast Cancer
3
Colonic Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Radiation Injuries
2
Papillomavirus Infections
2
Carcinoma, Hepatocellular
2
Advanced Breast Cancer
2
Interventions
Docetaxel
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
UNKNOWN
×
Skin Diseases
×
Clear all
NCT01917279
2020-07-23
CAMELLIA
ChineseAMS
Phase 3
Unknown
280 enrolled